GS Acquisition Holdings Corp II

GSAH-UN • Shell Companies

$15.24

— 0.00 (0.00%)

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$4.20B

Crecimiento

-2.1%

Flujo de caja

4/5

Tendencia

Mostly stable

Evidencia

Crecimiento positivo de ingresos · 5.8%Flujo de caja libre positivo · 0.46Flujo de caja libre consistente · 4/5Nivel de deuda manejable · 0.68Liquidez saludable · 2.84

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 5 ago 2026, 2:27 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$15.24

Change0.00%

Shares Out275.36M

Market Cap$4.20B

Enterprise Value$4.99B

52W Range11.13 - 11.23

Beta0.00

P/E171.28

P/S4.09

P/B2.30

P/FCF30.68

EV/Sales4.87

Price$15.24

Change0.00%

Shares Out275.36M

Market Cap$4.20B

Enterprise Value$4.99B

52W Range11.13 - 11.23

Beta0.00

P/E171.28

P/S4.09

P/B2.30

P/FCF30.68

EV/Sales4.87

EV/EBITDA23.32

EV/FCF36.46

Earnings Yield0.58%

FCF Yield3.26%

Dividend Yield0.00%

Gross Margin47.40%

Oper. Margin5.57%

Profit Margin3.11%

Debt/Eq0.68

Current Ratio2.84

Quick Ratio2.36

Revenue 5Y-2.10%

FCF 5Y46.87%

Target$23.00

Target Upside50.92%

Target Median$23.00

Target Range20.00 - 28.00

Volume6.25K

Avg Volume4.59K

EPS Surprise0.00

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

41/100

Fortaleza financiera

Deuda, caja, estabilidad

72/100

Potencial de crecimiento

Ingresos y expansión

85/100

Atractivo del precio

Barata o cara hoy

39/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 5.8%Flujo de caja libre positivo · 0.46Flujo de caja libre consistente · 4/5Nivel de deuda manejable · 0.68Liquidez saludable · 2.84Múltiplo de ganancias caro · 187

Analyst view

Analyst sentiment and price target

MIR

Analyst sentiment

Based on 9 analyst votes · 2026-10-20

94/100

Bullish

Hold

Bearish

Precio objetivo

2026-07-31

Bajo

$23.00

Promedio

$25.80

Mediana

$25.00

Alto

$29.00

Resumen de la compañía

IPO: 6/30/2020

Industria: Shell Companies

P/B i: 2.30

Deuda / Patrimonio i: 0.68

Margen operativo: 5.57%

Margen neto: 3.11%

ROE i: -

ROIC: -

Salud financiera

Puntaje14 / 20

Deuda / Patrimonio: 0.68

Ratio corriente: 2.84

Ratio rápido: 2.36

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

⚠ 2 venta interna de alto volumens detectadas

Kingsley Lawrence D

Transacción: 06/30/2026

COMPRA

Cambio

+1,095

Precio

$17.46

Presentación

06/30/2026

Tipo

COMPRA

Rege Sheila

Transacción: 05/13/2026

COMPRA

Cambio

+7,383

Precio

Not reported

Presentación

05/14/2026

Tipo

COMPRA

Markopoulos Jody

Transacción: 05/13/2026

COMPRA

Cambio

+7,383

Precio

Not reported

Presentación

05/14/2026

Tipo

COMPRA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Kingsley Lawrence D	COMPRA	+1,095	$17.46	06/30/2026	06/30/2026
Rege Sheila	COMPRA	+7,383	Not reported	05/13/2026	05/14/2026
Markopoulos Jody	COMPRA	+7,383	Not reported	05/13/2026	05/14/2026
KUO JOHN W	COMPRA	+7,383	Not reported	05/13/2026	05/14/2026
Etzel Steven W.	COMPRA	+7,383	Not reported	05/13/2026	05/14/2026
CASCELLA ROBERT	COMPRA	+7,383	Not reported	05/13/2026	05/14/2026
Bockhorst Kenneth	COMPRA	+7,383	Not reported	05/13/2026	05/14/2026
Kingsley Lawrence D	COMPRA	+7,383	Not reported	05/13/2026	05/14/2026
Moore Christopher A.	VENTA	-8,400	$19.64	05/07/2026	05/08/2026
Logan Thomas D	VENTA	-311,851	Not reported	05/06/2026	05/07/2026
Lee Emmanuelle	VENTA	-4,680	$18.59	04/01/2026	04/02/2026
Logan Thomas D	VENTA	-22,614	$18.59	04/01/2026	04/02/2026
Moore Christopher A.	VENTA	-1,903	$18.59	04/01/2026	04/02/2026
Schopfer Brian	VENTA	-7,377	$18.59	04/01/2026	04/02/2026
Ulrich Alison	VENTA	-2,053	$18.59	04/01/2026	04/02/2026
Kingsley Lawrence D	COMPRA	+1,104	$17.32	03/31/2026	04/02/2026
Logan Thomas D	VENTA	-3,093,812	Not reported	03/02/2026	03/03/2026
Schopfer Brian	VENTA	-28,499	$21.61	03/02/2026	03/03/2026
Eloy Loic	COMPRA	+15,577	Not reported	03/02/2026	03/03/2026
Logan Thomas D	VENTA	-20,650	$21.61	03/01/2026	03/03/2026

Sobre la compañía

Mirion Technologies, Inc.

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

Fuente - Link

Competidores

GTES GXO JBTM MIDD MOG-A NPO PONY REZI ROAD

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Mirion Extends Support of IAEA Mission to Advance Cancer Care Globally through Rays of Hope Donation

ATLANTA--(BUSINESS WIRE)--Mirion, a leading provider of advanced radiation safety solutions, has announced support for the International Atomic Energy Agency (IAEA) Rays of Hope initiative, which aims to help address disparities in access to quality cancer diagnosis and treatment in Low- and Middle-Income Countries (LMIC). This milestone builds on the partnership agreement signed between Mirion and the IAEA in September 2025, which formalized Mirion's support for the Agency's mission to enhance.

Business Wire

Mirion Technologies, Inc. (MIR) Reports Next Week: What You Should Expect

Mirion Technologies (MIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research

Mirion Announces Earnings Release and Conference Call Date for Third Quarter 2026

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for third quarter 2026 after market close on Tuesday, October 27, 2026. Following the news release, the company will host a conference call the next day, Wednesday, October 28, 2026, at 10:00 am ET to discuss the results. A live webcast and the subsequent replay will be available at https://mirion-3q-2026.open-exchange.net. About Mirion Mirion (NYSE: MIR) is a global leader in radiation safety, s.

Business Wire

A Look at Mirion Technologies Inc (MIR) After 3.2% Decline -- GF Value $15.60 vs Price $15.90

On October 14, 2026, Mirion Technologies Inc (MIR) shares fell 3.2%, closing at $15.90. The stock has experienced significant volatility over the past year, wit

GuruFocus

Does Mirion Technologies (MIR) Have the Potential to Rally 47.97% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 48% in Mirion Technologies (MIR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-04-28	0.1	0.1	0
2026-02-10	0.16	0.15	-0.01
2025-10-28	0.11	0.12	0.01
2025-07-31	0.1	0.11	0.01
2025-04-29	0.1	0.1	0
2025-02-11	0.14	0.17	0.03
2024-10-29	0.11	0.08	-0.03
2024-08-01	0.08	0.1	0.02
2024-04-30	0.06	0.06	0
2024-02-13	0.14	0.15	0.01
2023-11-01	0.05	0.05	0
2023-08-02	0.06	0.08	0.02